BioCryst Raises 2026 Revenue Outlook After Strong Q2—ORLADEYO Growth and Pipeline Advances Highlight Momentum
Market Chameleon (Wed, 5-Aug 7:37 AM)
BioCryst Pipeline Focus Shifts: External Innovation Takes the Lead as Internal Discovery Winds Down
Market Chameleon (Mon, 29-Jun 7:29 AM)
BioCryst Data Shows ORLADEYO Consistently Reduces HAE Attack Frequency Across Age Groups and Real-World Settings
Market Chameleon (Fri, 12-Jun 7:08 AM)
